Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

February 14, 2017 - 7:01 p.m.
Gilead Announces 144-Week Data Evaluating Safety and Efficacy of Genvoya® for Treatment of HIV-1 in Treatment-Naïve AdultsPrinter Friendly Version 
February 13, 2017 - 6:47 p.m.
Gilead Announces Findings from New Preclinical Study Evaluating Novel Class of HIV Capsid InhibitorsPrinter Friendly Version 

Upcoming Events

There are currently no events scheduled.

Most Viewed Links

Updated 02/19/17
1.SEC Filings
2.Earnings
3.Annual Reports
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 02/11/17 - 02/18/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$69.94
 Stock is Up 0.57 (0.82%)
Data as of 02/24/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Fourth Quarter 2016 Gilead Sciences Earnings Conference Call

February 07, 2017 4:30 p.m. ET
Play
Gilead Sciences at 35th Annual J.P. Morgan Healthcare Conference

January 09, 2017 10:30 a.m. PT
Play